During the past decade, Azienda Ospedaliera Sant'Anna conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Azienda Ospedaliera Sant'Anna" #1 sponsor was "Gruppo Italiano per lo studio dei Carcinomi dell'Apparato Digerente" with 2 trials, followed by "Gianluca Botto" with 1 trials sponsored, "Istituto Oncologico Veneto IRCCS" with 1 trials sponsored, "Italian Sarcoma Group" with 1 trials sponsored and "Morphotek" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Azienda Ospedaliera Sant'Anna" #1 collaborator was "Dipartimento di scienze chirurgiche, Oncologiche e Gastroenterologiche" with 1 trials as a collaborator, "Eisai Europe Ltd. (United Kingdom)" with 1 trials as a collaborator, "Istituto Di Ricerche Farmacologiche Mario Negri" with 1 trials as a collaborator, "Istituto Nazionale Tumori di Napoli" with 1 trials as a collaborator and "Regione Lombardia" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Azienda Ospedaliera Sant'Anna" are "Advanced Breast Cancer" (1 trials), "First Degree Atrioventricular Block" (1 trials), "Leiomyosarcoma" (1 trials), "Liposarcoma" (1 trials) and "Locally Advanced Unresectable Gastric Cancer" (1 trials). Many other conditions were trialed in "Azienda Ospedaliera Sant'Anna" in a lesser frequency.

Most popular intervention types in "Azienda Ospedaliera Sant'Anna" are "Drug" (6 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Abemaciclib" (1 trials), "Aromatase Inhibitors" (1 trials), "Capecitabine" (1 trials), "Carboplatin" (1 trials) and "Cardiac resynchronization therapy pacemaker" (1 trials). Other intervention names were less common.

The vast majority of trials in "Azienda Ospedaliera Sant'Anna" are 6 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Azienda Ospedaliera Sant'Anna". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Azienda Ospedaliera Sant'Anna, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Azienda Ospedaliera Sant'Anna, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".

Azienda Ospedaliera Sant'Anna has several departments that took part in Clinical trials: "Ospedale S. Anna - U.O.C. Di Cardiologia" - 4 trials, "ASST LARIANA; Oncologia" - 2 trials